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Introduction {#sec1}
============

As a minimally invasive and toxic strategy, photodynamic therapy (PDT) has been popularly studied in clinical fields for localized and superficial cancer treatment ([@bib17], [@bib28], [@bib38]). PDT is easily performed; it utilizes a light source to activate the administered photosensitizing molecules conjugated with molecular oxygen (O~2~) to generate cytotoxic singlet oxygen (^1^O~2~) or other kinds of reactive oxygen species (ROS) to induce cell death ([@bib4], [@bib12], [@bib18], [@bib55]). In addition to directly killing cancer cells, PDT appears to shrink or destroy tumors by damaging blood vessels in the tumor or by activating the immune system to attack cancer cells ([@bib13], [@bib22]). The O~2~-involved therapeutic effect of PDT has remarkably improved the selectivity and side effects of traditional therapeutic agents for cancer therapy ([@bib1], [@bib33], [@bib42]). However, the efficiency of PDT is always limited by the rapid O~2~ consumption because of the O~2~-dependent treatment process ([@bib21], [@bib30], [@bib35]). More importantly, the rapid proliferation of cancer cells as well as the distorted tumor blood vessels would further lower the O~2~ supply, leading to hypoxia in the tumor site and hindering the O~2~-involved cancer therapy ([@bib2], [@bib45], [@bib50], [@bib52], [@bib56]).

Over the past decade, two strategies have been mainly explored for enhancing O~2~ supply against pre-existing hypoxia in the tumor site. One is to increase the O~2~ concentration in the tumor site by applying intelligent nanoparticles (NPs) to deliver O~2~ during blood circulation ([@bib8], [@bib10]). The other one is to directly produce O~2~ in the tumor site by using NPs to catalyze abundant hydrogen peroxide (H~2~O~2~, usually ranging from 100 μM to 1 mM) in cancer cells resulting from the excess ROS due to tumor hypoxia ([@bib23], [@bib40]). Up to now, all kinds of NP-based nanocatalysts (NCs) have been used for H~2~O~2~ decomposition and O~2~ generation to relieve the tumor hypoxia, such as MnO~2~, CaO~2~, carbon nitride (C~3~N~4~), carbon dot, and biological catalase ([@bib6], [@bib11], [@bib14], [@bib19], [@bib20], [@bib57]). The NCs demonstrate an excellent activity for increasing endogenous O~2~ supply, and therefore could generate more cytotoxic ^1^O~2~ for increase in cancer cell death under near-infrared (NIR) irradiation ([@bib15]). Although NC-based PDT has shown great potential for cancer treatment, the excess use of photosensitizers to ensure decent therapeutic efficacy still causes severe side effects, including strong light sensitivity and multiple pain in patients ([@bib5], [@bib44]). Meanwhile, the unpredictable toxicities and uncontrollable catalytic processes of the reported NCs obviously limits their clinical application ([@bib3], [@bib34], [@bib37]). Thus there is an urgent demand for the development of biocompatible NCs that exhibit stimuli-responsive O~2~ supply and simultaneously transform O~2~ to cytotoxic ^1^O~2~ for enhanced PDT efficiency in a synergistic manner.

Here, we report a safe multifunctional platform as NC for photo-controlled O~2~ generation from endogenous H~2~O~2~ decomposition and imaging-guided photo-enhanced cancer therapy. All compositions in the NCs have been approved by the US Food and Drug Administration (FDA). Prussian blue (PB) is selected as the building block due to its imaging function and catalase-like activity for H~2~O~2~ decomposition ([@bib9], [@bib51], [@bib53]). It is also expected to control the H~2~O~2~ decomposition by local temperature variation of PB irradiated with NIR laser because of the photothermal conversion ability of PB NPs. Mesoporous silica is used to coat PB NPs and provide a space for the loading of targeted molecules. After being modified with polyethylene glycol (PEG) molecules, the resultant PB\@SiO~2~-PEG (named as PSP) NCs will possess good aqueous stability, excellent biocompatibility, and long blood circulation time. Zinc phthalocyanine (ZnPc) is chosen as a photosensitizer model because of its overlapping maximum NIR absorption with PB NPs, which can avoid the time interval between photothermal conversion and PDT of NCs ([@bib25], [@bib32]). Both *in vitro* and *in vivo* results show that the PSP-ZnPc (PSPZP) NCs can enhance photodynamic efficacy for cancer therapy under NIR irradiation since the increase in local temperature of photo-enhanced NCs could improve *in situ* O~2~ generation at the tumor site.

Results {#sec2}
=======

Preparation and Characterization of the PSPZP NCs {#sec2.1}
-------------------------------------------------

[Figure 1](#fig1){ref-type="fig"}A demonstrates the synthetic process of multifunctional PSP NCs with enhanced photo-induced O~2~ and ^1^O~2~ generation. The PB template NPs (see [Transparent Methods](#mmc1){ref-type="supplementary-material"}) possess a uniform size distribution (∼80 nm) and cube-like shape ([Figures 1](#fig1){ref-type="fig"}B and [S1](#mmc1){ref-type="supplementary-material"}). After being coated with mesoporous silica through the Stöber method, the as-obtained PB\@SiO~2~ NPs demonstrate a core-shell structure with an average size of 100 nm ([Figure 1](#fig1){ref-type="fig"}C). Powder X-ray diffraction pattern and Fourier transform infrared spectroscopy ([Figures S2](#mmc1){ref-type="supplementary-material"} and [S3](#mmc1){ref-type="supplementary-material"}) confirmed the successful coating of silica on the surface of PB template as evidenced by the existence of asymmetric stretching (1,082 cm^−1^) and symmetric vibration (797 cm^−1^) of Si-O-Si and Si-OH (950 cm^−1^) ([@bib46]). The PB\@SiO~2~ NPs were further functionalized with amino groups (-NH~2~) with (3-aminopropyl)triethoxysilane, followed by PEGylation with Mal-PEG-SCM (SCM: succinimide; and Mal: maleimide) via amino-SCM click reaction, leading to the formation of biocompatible PSP NCs.Figure 1Synthesis and Characterization of the PSP NCs(A) Schematic of the synthetic procedure and photo-enhanced therapy of the PSPZP NCs.(B--D) Transmission electron micrographs of (B) PB NPs, (C) PB\@SiO~2~ NPs, and (D) PSP NCs. The photograph at the right side in (D) shows aqueous PSP dispersion in a vial.(E) The elemental (Si, O, N, Fe) mappings of PSP NCs.

Transmission electron microscopy (TEM) ([Figure 1](#fig1){ref-type="fig"}D) shows that PSP NCs have a good monodispersity with an average size of 120 nm. The elemental mapping data ([Figure 1](#fig1){ref-type="fig"}E) of single PSP NCs show that the elements of Fe and N are mainly distributed in the core, whereas Si and O are homogenously distributed in the shell, indicating its core-shell shape with a PB core and SiO~2~ shell. The hydrodynamic diameter distribution (∼140 nm) of PSP NCs measured by dynamic light scattering is slightly larger than that measured by TEM because of the presence of PEG chains on the surface of NCs ([Figure S4](#mmc1){ref-type="supplementary-material"}). The variation of zeta potential of PB\@SiO~2~ (−32.5 ± 4.3 mV) and PSP NCs (3.2 ± 2.2 mV) reveals that the PEG chains had been successfully immobilized onto the surface of silica ([Figure S5](#mmc1){ref-type="supplementary-material"}). The PEG modification endows excellent stability to the NCs in PBS and saline solutions even after being stored for 20 months ([Figure S6](#mmc1){ref-type="supplementary-material"}).

[Figure 2](#fig2){ref-type="fig"}A manifests the UV/visible (Vis) absorption spectra of the PB, PSP, ZnPc, and PSPZP NCs. The great overlap between PSP NCs and ZnPc enables PSPZP to function as a combined photothermal/photodynamic agent under the same excitation wavelength using a single NIR laser. [Figure 2](#fig2){ref-type="fig"}B shows the photo-induced temperature increase of PSP NCs at different concentrations. Upon 10-min NIR irradiation (671 nm, 0.4 W cm^−2^), the temperature of the PSP solution (200 ppm) is raised by 25°C, which confirmed the photothermal conversion of PSP NCs ([@bib39], [@bib43]). The UV/Vis absorption spectra of PSP NCs after six heating-cooling cycles have similar intensity, indicating the remarkable stability of NCs under NIR irradiation ([Figures S7](#mmc1){ref-type="supplementary-material"} and [S8](#mmc1){ref-type="supplementary-material"}). To investigate the ability of PSP NCs for photo-enhanced H~2~O~2~ decomposition due to the photothermal conversion of NCs, we carried out time-dependent H~2~O~2~ assay under different temperatures. As shown in [Figure 2](#fig2){ref-type="fig"}C, more than 50% of H~2~O~2~ can be decomposed within 1 hr at room temperature (25°C). The immediate formation of abundant O~2~ bubbles also reveals the strong catalytic capability of PSP NCs once the NCs were added into H~2~O~2~ solution ([Figure 2](#fig2){ref-type="fig"}C, inset). With the increase in aqueous temperature (from 25°C to 43°C), the decomposition rate of H~2~O~2~ showed an obvious trend of growth. As we know the decomposition reaction of H~2~O~2~ is a first-order reaction. The calculated catalytic reaction rate constant under 43°C is 0.0335 min^−1^, which is 1.93 times than that under 25°C (0.0174 min^−1^). The generated O~2~ was measured by an oxygen probe (JPBJ-608 portable Dissolved Oxygen Meters, Shanghai REX Instrument Factory) ([Figure 2](#fig2){ref-type="fig"}D). The result showed that the concentration of dissolved O~2~ at 43°C is 1.95 times that at 25°C. Such improved H~2~O~2~ decomposition at higher temperature would make for the increase in PDT efficiency of PSP NCs due to the accelerated O~2~ supply. Furthermore, the catalytic activity of the PSP NCs has no obvious change after repetitive H~2~O~2~ decomposition ([Figure 2](#fig2){ref-type="fig"}E), indicating their excellent catalytic stability.Figure 2Characterization of Photothermal and Photodynamic Efficacies(A) UV/Vis absorption spectra of PB, PSP, ZnPc, and PSPZP (dispersed in DMSO).(B) Temporal temperature evolutions of PSP solutions at various concentrations under NIR irradiation (671 nm, 0.4 W cm^−2^).(C and D) Decomposition (C) and O~2~ generation (D) of H~2~O~2~ treated with PSP NCs or not treated under various temperatures (25°C, 37°C, 40°C, and 43°C).(E) The catalytic ability of PSP NCs with repetitive addition of H~2~O~2~ at room temperature.(F) Singlet oxygen generation efficiency determined by 1,3-diphenylisobenzonfuran (DPBF) under various conditions.Error bars were based on the standard error (mean ± SEM, n = 3).

Characterization of Photothermal and Photodynamic Efficacy {#sec2.2}
----------------------------------------------------------

Full nitrogen sorption isotherms were obtained to measure the porous properties of PSP NCs. As shown in [Figure S9](#mmc1){ref-type="supplementary-material"}, the Brunauer-Emmett-Teller surface area, pore volume, and pore size of PSP NCs are 427.6 m^2^ g^−1^, 0.375 cm^3^ g^−1^, and 2.82 nm, respectively. The mesoporous shell and large surface area of PSP NCs make them suitable as carriers for photosensitizer loading. The loading capacity was determined by calculating the absorbance change of the characteristic absorption peak of ZnPc ([Figure S10](#mmc1){ref-type="supplementary-material"}). Results showed that each PSP particle could load about 18,800 ZnPc molecules. Given the effective catalytic ability of PSP for O~2~ generation, PSPZP NCs have great potential as ^1^O~2~ supplier for PDT. The produced ^1^O~2~ was determined by measuring the bleaching of 1,3-diphenylisobenzonfuran at 421 nm under Ar atmosphere. Notably, in comparison with the absence of H~2~O~2~, a significant increase in ^1^O~2~ generation by PSPZP was observed in the presence of H~2~O~2~ ([Figure 2](#fig2){ref-type="fig"}F) at room temperature. Since the inert atmosphere has completely maintained the hypoxic condition in catalytic system, the increased ^1^O~2~ generation should come from PSPZP-induced H~2~O~2~ decomposition and O~2~ generation. Importantly, the ^1^O~2~ generation can be controlled through the variation of local temperature (from 25°C to 37°C), indicating that the PDT efficiency of PSPZP NCs should be improved by the photo-induced temperature change resulting from the photothermal conversion effect of NCs under NIR irradiation.

Before conducting the PDT of PSPZP *in vitro*, the endogenous H~2~O~2~ decomposition and O~2~ generation of PSP NCs was assessed. As shown in [Figure 3](#fig3){ref-type="fig"}A, strong green fluorescence shows the high H~2~O~2~ level in 4T1 cells in hypoxic condition when treated with 100 μM H~2~O~2~. The decrease in fluorescence intensity of the cells treated with PSP NCs indicated that the PSP could efficiently perform endogenous H~2~O~2~ decomposition. The disappearance of fluorescence intensity of the cells treated with PSP NCs under NIR irradiation further showed that the external laser could speed up the H~2~O~2~ decomposition. In addition, to further evaluate the O~2~ generation *in vitro*, an O~2~ indicator \[Ru(dpp)~3~\]Cl~2~ was applied to monitor the endogenous O~2~ level ([Figure 3](#fig3){ref-type="fig"}B). 4T1 cells incubated under hypoxia condition exhibited the strongest red fluorescence intensity due to the insufficient O~2~ supply. After being treated with PSP NCs, the reduction in the fluorescence intensity indicates O~2~ generation due to endogenous H~2~O~2~ decomposition, especially with the addition of NIR irradiation. The aforementioned results reveal that PSP NCs can significantly alleviate endogenous hypoxia *in vitro* via *in situ* H~2~O~2~ decomposition and O~2~ generation under NIR irradiation. The cytotoxicities of PSP and PSPZP NCs with/without NIR irradiation under hypoxic and normoxic conditions were evaluated. As shown in [Figure S11](#mmc1){ref-type="supplementary-material"}, more than 87% of cells from three cell lines (4T1, HeLa, and A549 cells) survived after 24-hr treatment with PSP at a concentration up to 200 μg mL^−1^. This indicates that PSP NCs are nontoxic to the tested cells. Meanwhile, 5-min NIR irradiation alone (when the concentration of NCs is 0 μg mL^−1^) has negligible toxicity in 4T1 cells ([Figures 4](#fig4){ref-type="fig"}A and 4B), which shows that the slight decrease in cell viability upon treatment by PSP and PSPZP NCs in hypoxic conditions should come from photothermal therapy (PTT) of NCs under NIR irradiation. The 24-hr treatments with PSPZP NCs in normoxic conditions have more cytotoxicity than treatments in hypoxic conditions. To mimic an H~2~O~2~-rich cancer microenvironment, 100 μM H~2~O~2~ was added into cell media in hypoxic conditions ([@bib40]). Results show that the introduction of H~2~O~2~ could greatly increase the cytotoxicity of PSPZP NCs under NIR irradiation, which should result from the increased ^1^O~2~ generation because the photothermal conversion of NCs could speed up the H~2~O~2~ decomposition and O~2~ generation. To further demonstrate the catalytic ability of PSP NCs, mesoporous silica NPs were synthesized through an etching process of PB\@SiO~2~ under alkaline solution (see [Transparent Methods](#mmc1){ref-type="supplementary-material"}). Transmission electron micrographs ([Figure S12](#mmc1){ref-type="supplementary-material"}) show that mesoporous silica without inner PB still maintains its original cubic morphology. Then, ZnPc-loaded mesoporous silica was used to study the O~2~-dependent PDT ability under hypoxic condition. Results indicated that without inner PB, H~2~O~2~ cannot be converted into O~2~, and thus the killing efficiency will be suppressed ([Figure S13](#mmc1){ref-type="supplementary-material"}). To further confirm the influence of temperature on PDT efficiency, we performed cell viability test of PSPZP NCs under different incubation temperatures. As shown in [Figure 4](#fig4){ref-type="fig"}C, with the increase in incubation temperature from 37°C to 43°C, greater cytotoxicities have been observed. Flow cytometry was used to conduct apoptosis analysis of annexin V-fluorescein isothiocyanate and propidium iodide double-stained 4T1 cells treated in different conditions. As shown in [Figure 4](#fig4){ref-type="fig"}D, an obvious increased apoptotic rate (Q2 + Q3) is present with the increase of incubation temperature. All *in vitro* cytotoxic results showed that the local temperature enhanced by the introduction of NIR irradiation plays a key role in increasing the O~2~ and ^1^O~2~ generation, therefore enhancing the PDT efficiency of PSPZP NCs.Figure 3Enhanced H~2~O~2~ Decomposition and O~2~ Generation of PSP NCs in Cells(A) Confocal laser scanning microscopy (CLSM) images of green fluorescent intracellular H~2~O~2~ in 4T1 cells incubated with PBS or PSP NCs treated or not treated by NIR irradiation. Scale bar, 50 μm.(B) CLSM images of 4T1 cells stained with O~2~ indicator ((Ru(dpp)~3~)Cl~2~) after different treatments (normoxia with PBS as control, hypoxia with PBS, hypoxia with PSP NCs, and hypoxia with PSP NCs plus NIR irradiation). Scale bar, 50 μm.Figure 4Enhanced Cytotoxicity by PSPZP NCs in Normal and Hypoxic Conditions(A and B) Viabilities of (A) normoxic and (B) hypoxic 4T1 cells treated with PSP or PSPZP with or without addition of H~2~O~2~ under NIR irradiation (671 nm, 0.4 W cm^−2^, 5 min).(C) Relative viabilities of 4T1 cells incubated with PSP or PSPZP NCs (PSP concentration in both NCs is 50 μg/mL) in normoxic (37°C) and hypoxic (37°C, 40°C, 43°C) environments under NIR irradiation (671 nm, 0.4 W cm^−2^, 5 min).(D) Flow cytometry analysis of 4T1 cells after receiving different treatments.Statistical analysis was performed using the Student\'s two-tailed test (^∗∗^p \< 0.01 and ^∗∗∗^p \< 0.001).

*In Vivo* Photoacoustic and Positron Emission Tomographic Imaging {#sec2.3}
-----------------------------------------------------------------

As a widely used noninvasive biomedical modality, photoacoustic imaging (PAI) is a newly developed method that employs laser light to acoustically visualize biological tissues ([@bib24]). Owing to the strong absorbance in the NIR region, PAI of PSP NCs was assessed *in vitro* and *in vivo*. Photoacoustic (PA) signals were first plotted as a function of PSP NCs concentration ([Figure S14](#mmc1){ref-type="supplementary-material"}), which has a linear relationship with a slope of 2.94. 4T1 tumor-bearing mice were selected as model for *in vivo* imaging. PSP NCs were administered through intravenous injection at a dose of 4 mg kg^−1^, and the excitation wavelength was fixed at 730 nm. Quantitatively, the average PA signal intensity was increased by 225.8% and 244.7% for tumor at 0.5 and 4 hr post-injection respectively, relative to the signal intensities of the tumor before the injection ([Figures 5](#fig5){ref-type="fig"}A and [S15](#mmc1){ref-type="supplementary-material"}).Figure 5*In Vivo* Photoacoustic and Positron Emission Tomography Imaging of PSP NCs(A) *In vivo* 2D ultrasonic and PA imaging of 4T1 tumor in mice injected with PSP NCs acquired at 0 hr and after post-injection (0.5 hr and 4 hr).(B) Schematic illustration showing the labeling of ^89^Zr^4+^ to the deprotonated silanol groups (-Si-O-) from the meso channels.(C) Quantified labeling yield of ^89^Zr on PSP NCs at various time points.(D) Stability test of ^89^Zr labeling on PSP NCs after incubation in serum at 37°C or 56°C for different periods of time.(E) PET images of 4T1 tumor-bearing mice taken at various time points (0.5, 3, 6, and 24 hr) after i.v. injection of ^89^Zr-PSP NCs. The green circles highlight the 4T1 tumor site of mice.(F) Biodistribution of ^89^Zr-PSP NCs in different organs at 24 hr after being injected into 4T1 tumor-bearing mice. The unit is the percentage of injected dose per gram of tissue (%ID/g).Error bars were based on the standard error (mean ± SEM, n = 3).

Positron emission tomography (PET) can offer high sensitivity and accurate quantification when compared with other imaging modalities. It has been widely employed in the field of molecular imaging for disease diagnosis, drug tracking, and treatment monitoring ([@bib41]). Radionuclide ^89^Zr has an optimal half-life (t~1/2~ = 78.4 hr) and relatively low positron energy (β^+^~avg~ = 395.5 keV), making it suitable for long-term *in vivo* tracking of NPs ([@bib54]). For these reasons, ^89^Zr-based radiopharmaceuticals are now being actively developed for clinical applications, with at least five clinical trials in the United States alone using ^89^Zr-labeled antibodies (many more in Europe) ([@bib7], [@bib16]). PET imaging was further used to evaluate tumor imaging and biodistribution of PSP NCs *in vivo*. As shown in [Figure 5](#fig5){ref-type="fig"}B, ^89^Zr^4+^ could be stably loaded into PSP NCs because the deprotonated silanol groups (-Si-O^-^) in mesoporous silica shell could function as hard Lewis acid sites for stable chelator-free radiolabeling of hard Lewis bases. Herein, results revealed that the labeling yields were 84.5% due to the presence of abundant deprotonated silanol groups inside the mesochannels of mesoporous silica ([Figure 5](#fig5){ref-type="fig"}C). To ensure the labeling stability of ^89^Zr, ^89^Zr-labeled PSP was mixed with mouse serum and shaken at 37°C and 56°C. By measuring the remaining radioactivities in those samples, we found that ^89^Zr-PSP was highly stable within 24 hr in serum ([Figure 5](#fig5){ref-type="fig"}D). The PSP NCs with stable ^89^Zr loading were then intravenously injected into mice. As shown in [Figure 5](#fig5){ref-type="fig"}E, the obvious tumor contrast was observed 6 hr after injection. These imaging results indicate that the PSP NCs could effectively remain in tumor site due to the enhanced permeability and retention effect of cancerous tumors, and therefore have a great potential for *in vivo* imaging-guided cancer therapy ([@bib29], [@bib48]). To further study the biodistribution of PSP NCs *in vivo*, mice treated with ^89^Zr-PSP NCs were sacrificed 24 hr after injection. The radioactivities in major tissues and organs were measured using a γ-counter ([Figure 5](#fig5){ref-type="fig"}F). In addition to the tumors, larger radioactivities were noted in the liver and spleen, which result from the clearance of foreign NPs by macrophage uptake ([@bib26], [@bib31]).

*In Vivo* PDT and PTT Using Intravenous Injection {#sec2.4}
-------------------------------------------------

To examine the photo-enhanced therapeutic efficacy of PSPZP NCs on treating tumors *in vivo*, mice bearing 4T1 tumor were administered NCs by intravenous injection, and tumors were then subjected or not subjected to NIR irradiation (671 nm, 0.4 W cm^−2^) for 5 min at 24 hr post-injection. Tumor-bearing mice were randomly divided into 6 groups with six mice per group. As shown in [Figure 6](#fig6){ref-type="fig"}A, mice injected with saline (control) and PSPZP demonstrated the greatest tumor growth. Similarly, NIR irradiation alone has no influence on tumor growth.Figure 6*In Vivo* PDT and PTT Using Intravenous Injection in a Subcutaneous Tumor Model(A) Relative tumor volume variation of mice treated under different conditions (n = 6).(B) Average body weights of mice that received different treatments.(C) Average weights and typical photographs (inset) of tumors collected from mice at the end of treatments (day 16).(D) Slices of tumor tissues stained with H&E after different treatments. Scale bar, 50 μm.(E) Optical microscopic images of tumor sections stained by Ki-67 from different groups. Scale bar, 50 μm.Statistical analysis was performed using the Student\'s two-tailed t test (^∗∗^p \< 0.01 and ^∗∗∗^p \< 0.001).

However, tumors in mice treated with ZnPc plus NIR and PSP plus NIR showed obvious reduced growth due to the PDT of ZnPc and PTT of PSP under NIR irradiation, respectively. Notably, a significant tumor inhibition was observed in mice treated with PSPZP plus NIR irradiation. After one round of this treatment, the tumors exhibited no further growth. In addition, mice in all treated groups showed a similar body increase tendency and did not show apparent weight loss ([Figure 6](#fig6){ref-type="fig"}B). At day 16, tumors from all groups were harvested and weighed ([Figure 6](#fig6){ref-type="fig"}C). The tumor weight in saline-, PSPZP-, or NIR-treated mice is larger than that of mice treated with ZnPc + NIR (PDT) or PSP + NIR (PTT). Importantly, compared with PDT or PTT treatment, the therapeutic efficacy achieved by the combinatory therapy (PSPZP + NIR) appeared to be much higher than the additive efficacy of PDT and PTT used alone based on the tumor growth reduction ratio at day 16, suggesting a synergistic effect of the combinatory therapy. As revealed by micrographs of an H&E-stained tumor slice, prominent cell damage was found in the tumor treated with PSPZP + NIR ([Figure 6](#fig6){ref-type="fig"}D). Besides, cancer cells show a higher suppressed proliferation in the PSPZP + NIR group as shown in the Ki-67 staining when compared with other groups ([Figure 6](#fig6){ref-type="fig"}E), further indicating the enhanced PDT efficacy. Based on the above results, the PSPZPs NCs demonstrated great potential as an excellent nanoplatform for enhanced PDT due to the photo-enhanced endogenous O~2~ generation for relieving tumor hypoxia.

*In Vivo* Anti-tumor Mechanism and Long-Term Biocompatibility Test {#sec2.5}
------------------------------------------------------------------

To investigate the ability of NCs to relieve tumor hypoxia *in situ* for cancer therapy, a hypoxyprobe (pimonidazole) immunofluorescence assay was carried out on tumor slices extracted from mice treated with PSP NCs for 24 hr. Anti-mouse CD31 antibody was used to locate blood vessels inside the tumor. Compared with the control group, the tumor slices from mice treated with PSP NCs showed obviously reduced green fluorescence (pimonidazole-stained hypoxia), indicating that the tumor hypoxia was relieved ([Figure 7](#fig7){ref-type="fig"}A). Semi-quantitative statistical analysis of hypoxia-positive areas and blood vessel densities based on nine confocal images further indicated that the PSP NCs, especially with the assistance of NIR irradiation, could greatly reduce tumor hypoxia without affecting blood vessel densities ([Figure 7](#fig7){ref-type="fig"}B). Moreover, a significant decrease of green fluorescence was observed in the group treated with PSP NCs plus NIR irradiation. Such photo-enhanced hypoxia improvement should come from the *in situ* increased endogenous H~2~O~2~ decomposition and O~2~ generation due to the NIR-enhanced local temperature enhancement ([Figure 7](#fig7){ref-type="fig"}C). Furthermore, to validate the delivery of PSP NCs to the interior of tumor, *in vivo* magnetic resonance (MR) imaging was performed as it can provide exquisite anatomical images with high spatial resolution without the restriction of imaging depth ([@bib36], [@bib47]). Upon intravenous injection of PSP NCs (20 mg/kg), T1-weighted MR signals gradually lighted up, whereas T2-weighted MR signals decreased in the interior region of tumor sites 24 hr later ([Figure S16](#mmc1){ref-type="supplementary-material"}), indicating that PSP NCs have been delivered to the interior of the tumor, which is considered to be hypoxia ([@bib49]).Figure 7*In Vivo* Anti-tumor Mechanism of PDT and PTT(A) Representative immunofluorescence images of tumor slices after hypoxia staining. The hypoxia areas and blood vessels were stained by anti-pimonidazole antibody (green) and anti-CD31 antibody (red), respectively. Scale bar, 50 μm.(B) The relative hypoxia-positive areas and blood vessel densities as recorded from nine images using the ImageJ software.(C) Full-body thermographic images of 4T1-tumor-bearing mice treated with saline and PSP NCs within 5-min NIR irradiation.

The hemolysis of PSPZP NCs was studied to test their safety *in vivo*. As shown in [Figure 8](#fig8){ref-type="fig"}A, no visible hemolytic effects (\<3%) were observed even at a PSP concentration up to 1,000 μg mL^−1^. The long-term toxicity of PSPZP NCs on healthy tissues was also investigated via *in vivo* blood biochemistry test, blood routine analysis, and H&E staining. The blood of healthy BALB/c mice was drawn from the tail artery at different time points (7 and 15 days) after intravenous injection of PSPZP NCs, whereas an untreated group was used as the control. For blood biochemistry test, alanine transaminase, alkaline phosphatase, aspartate aminotransferase, and blood urea nitrogen served as hepatic and renal function markers. As shown in [Figures 8](#fig8){ref-type="fig"}B and 8C, no significant changes were observed between control, 7 days, and 15 days, indicating the good hepatic and renal safety property of PSPZP NCs. For blood routine analysis, parameters such as red blood cells, white blood cell, hemoglobin, mean corpuscular hemoglobin concentration, platelets, mean corpuscular hemoglobin, mean platelet volume, mean corpuscular volume, and hematocrit were measured ([Figures 8](#fig8){ref-type="fig"}D--8L). All the nine markers are well within the normal ranges, suggesting the negligible *in vivo* toxicity of PSPZP at the treatment dose within 15 days ([@bib27]). The potential toxicity of nanoscale therapeutic agent has been a major safety concern for clinical applications. To test the biocompatibility of the NCs *in vivo*, we performed histological analysis on various tissues (heart, kidney, liver, lung, and spleen) from mice injected with PBS, PB NPs, mSiO~2~, PSP NCs, and PSPZP NCs to identify signs of acute toxicity. Tissues were harvested from mice 120 hr after NC injection, fixed in 10% formalin, embedded in paraffin, sectioned, and stained with H&E. As shown in [Figure 9](#fig9){ref-type="fig"}, no obvious tissue damage or inflammatory lesion in these main organs was observed, which indicates that all samples have no obvious damage in normal tissues. Thanks to the FDA-approved compositions in the nanostructure, the reported NCs herein are nontoxic and safe and suitable for biomedical applications.Figure 8Long-Term Biocompatibility Test(A) Hemolysis of PSPZP NCs at various concentrations.(B) The levels of alanine transaminase (ALT), alkaline phosphatase (ALP), and aspartate aminotransferase (AST) of untreated mice (control) and PSPZP NC-injected mice at 7 and 15 days.(C) The level of blood urea nitrogen (BUN) of untreated mice (control) and PSPZP NC-injected mice at 7 and 15 days.(D--L) Hematology data of red blood cell (RBC) (D), white blood cell (WBC) (E), hemoglobin (HGB) (F), mean corpuscular hemoglobin concentration (MCHC) (G), platelet (PLT) (H), mean corpuscular hemoglobin (MCH) (I), mean platelet volume (MPV) (J), mean corpuscular volume (MCV) (K), and hematocrit (HCT) (L) in the untreated mice (control) and in mice treated with the PSPZP NCs. Error bars were based on the standard error (mean ± SEM, n = 3).Figure 9H&E StainingH&E-stained tissue sections of mouse heart, kidney, liver, lung, and spleen obtained from saline-injected animals, and those injected with PB NPs, mSiO~2~, PSP NCs, and PSPZP NCs. Scale bar, 50 μm.

Discussion {#sec3}
==========

In summary, multifunctional and safe PSP NCs have been successfully synthesized by the surface coating of biocompatible PB NPs with mesoporous silica shell modified with PEG chains. Combining each function of building blocks, the as-synthesized PSP NCs not only maintain the properties of the individual constituents but also display cooperative properties for photo-enhanced H~2~O~2~ decomposition and O~2~ generation. *In vitro* and *in vivo* results show that the single laser-induced ^1^O~2~ generation could *in situ* relieve cancer hypoxia for enhanced cancer therapy by combined photothermal therapy/PDT. The NIR absorption and the ^89^Zr loading of PSP endow NCs the dual-modal PET and PAI imaging function to identify the tumor location and monitor the treatment progress. Such designed NCs demonstrate great promise toward advanced nanoplatforms for simultaneous imaging diagnostics and high-efficacy therapy.

Limitations of Study {#sec3.1}
--------------------

This work proposes a new possibility to construct multifunctional system through photo-induced local temperature enhancement for modulating catalytic reaction toward tumor-overexpressed hydrogen peroxide for augmented PDT. Although demonstrated experimentally, the low tumor accumulation and lack of targeting agent limit the further optimization of treatment efficiency for such a multifunctional system.

Methods {#sec4}
=======

All methods can be found in the accompanying [Transparent Methods supplemental file](#mmc1){ref-type="supplementary-material"}.
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Document S1. Transparent Methods and Figures S1--S16
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